ANI PharmaceuticalsANIP
About: ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Employees: 897
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
13% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 60
1.79% more ownership
Funds ownership: 90.19% [Q3] → 91.98% (+1.79%) [Q4]
0% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 31
1% less funds holding
Funds holding: 207 [Q3] → 204 (-3) [Q4]
6% less capital invested
Capital invested by funds: $1.14B [Q3] → $1.07B (-$72.4M) [Q4]
69% less call options, than puts
Call options by funds: $188K | Put options by funds: $597K
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Guggenheim Vamil Divan 34% 1-year accuracy 10 / 29 met price target | 24%upside $86 | Buy Reiterated | 11 Apr 2025 |
HC Wainwright & Co. Oren Livnat 48% 1-year accuracy 24 / 50 met price target | 36%upside $94 | Buy Reiterated | 17 Mar 2025 |
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 16%upside $80 | Buy Initiated | 14 Mar 2025 |
JP Morgan Ekaterina Knyazkova 100% 1-year accuracy 1 / 1 met price target | 23%upside $85 | Overweight Initiated | 12 Mar 2025 |
Financial journalist opinion
Based on 15 articles about ANIP published over the past 30 days
